biotech · Atopic Dermatitis · Moderate to Severe Atopic Dermatitis · KYMR
Kymera Therapeutics
Kymera Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 500 North Beacon Street, 4th Floor, Watertown, MA 02472, US
- Founded
- 2016
- Employees
- 289
- Programs
- 12
- Drugs
- 6
- Patents
- 29
Kymera Therapeutics clinical trials
Registry index of 13 ClinicalTrials.gov studies linked to Kymera Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Kymera Therapeutics trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Kymera Therapeutics.
-
KT621-AS-202 — Phase 2
Clinical update -
KT621-AD-201 — Phase 2
Clinical update -
KT-474/Placebo — Phase 1
Clinical update -
KT-621 — Phase 2
Clinical update -
KT-621 — Phase 2
Clinical update -
SAR444656 (KT-474) — Phase 2
Clinical update -
SAR444656 (KT-474) — Phase 2
Clinical update -
KT-253 — Phase 1
Clinical update